Eye surface and cataract surgery: Focus on Biotechnologies

Article

What are the best options of protecting and hydrating the epithelium during surgical procedures. The importance of the mucin protective layer on the corneal surface and implications for thiomer technology. Safety improvements with advanced fluidic technology systems: the need for a good machine to guarantee a precise flow control. Latest update on in vivo measurement methods of the accommodation in humans. Consequences and impacts on the IOL conception and design.

What are the best options of protecting and hydrating the epithelium during surgical procedures. The importance of the mucin protective layer on the corneal surface and implications for thiomer technology. Safety improvements with advanced fluidic technology systems: the need for a good machine to guarantee a precise flow control. Latest update on in vivo measurement methods of the accommodation in humans. Consequences and impacts on the IOL conception and design.

At this year's ESCRS Croma's symposia addressed those issues and also announced what it regards as a revolutionary new treatment for dry eyes in the form of a new generation of eye drops using Thiomer technology.

According to Croma this new patented technology of polymers has intrinsic natural stabilizing capabilities of the tear film. These connect directly with the mucus layer of the eye and results, say the company, have shown long-lasting ocular residence time. The thiolated polymers are hydrophilic macromolecules that exhibit free thiol groups on the polymeric backbone.

A report on the Croma symposium will follow at a later date in an issue of OTEurope.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.